StarTric
Milan
About StarTric
StarTric developes and is taken to clinical use as a transcatheter structural heart implantable device. They are developing a unique transcatheter repair implantable device to treat TR. They manage entrance to the right atrium, reducing the flow to the lungs. They offer heart failure, atrial fibrillation, and other morbidities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $11.4M
- Last round: Grant (Feb 2025)
- Website: startric.it
Industries & Categories
Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/startric-15506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.